Cardiovascular Surgery Devices and Equipment Market Report 2026

The cardiovascular surgery devices and equipment market size has grown marginally in recent years. It will grow from $1.8 billion in 2025 to $1.82 billion in 2026 at a compound annual growth rate (CAGR) of 0.7%. The growth in the historic period can be attributed to increasing incidence of cardiovascular disorders, expansion of cardiac surgery procedures, availability of advanced surgical equipment, growth in specialized cardiac hospitals, rising adoption of bypass and ablation systems.

The cardiovascular surgery devices and equipment market size is expected to see steady growth in the next few years. It will grow to $2.06 billion in 2030 at a compound annual growth rate (CAGR) of 3.1%. The growth in the forecast period can be attributed to increasing demand for less invasive cardiac interventions, rising investments in advanced surgical platforms, expansion of hybrid cardiac operating rooms, growing use of ai-assisted surgical planning, continuous innovation in cardiovascular surgical devices. Major trends in the forecast period include increasing adoption of minimally invasive cardiac surgery devices, rising use of advanced cardiac ablation technologies, growing precision in cardiopulmonary bypass systems, expansion of beating heart surgery techniques, enhanced focus on surgical outcome optimization.

The rising geriatric population is expected to drive growth in the cardiovascular surgical devices and equipment market in the coming years. The geriatric population includes individuals aged 65 years and older, who often experience increased healthcare needs due to age-related physiological changes and a higher prevalence of chronic conditions. Cardiovascular surgical devices support this population by enabling safer, minimally invasive procedures that address age-related heart conditions and improve survival rates and quality of life. For example, in October 2025, according to the World Health Organization, a Switzerland-based intergovernmental organization, the number of people aged 80 years or older is projected to triple to 426 million between 2020 and 2050. Consequently, the growing geriatric population is fueling the cardiovascular surgical devices and equipment market.

Leading companies in the cardiovascular surgical devices and equipment market are focusing on developing innovative solutions, such as CardioVisio for Atrial Fibrillation (AFib), to enhance early diagnosis, improve patient outcomes, and streamline treatment workflows. CardioVisio for AFib is an advanced diagnostic and monitoring tool designed to detect and manage AFib, a common irregular heart rhythm. For instance, in August 2023, GE HealthCare, a U.S.-based medical technology company, launched CardioVisio for AFib at the ESC Congress 2023. This digital clinical decision support system integrates longitudinal patient data from multiple sources, providing clinicians with a comprehensive overview of heart health. By delivering evidence-based recommendations aligned with AFib guidelines, CardioVisio improves adherence to best practices and streamlines clinical workflows.

In May 2024, Johnson & Johnson, a U.S.-based pharmaceutical company, acquired Shockwave Medical for an undisclosed amount. This acquisition strengthens Johnson & Johnson’s cardiovascular portfolio and enhances its position in minimally invasive vascular treatment technologies. Shockwave Medical Inc., a U.S.-based company, develops and commercializes innovative products for the treatment of cardiovascular disease.

Major companies operating in the cardiovascular surgery devices and equipment market are Abbott Laboratories, Boston Scientific Corporation, Cook Medical, Abiomed Inc., TransMedics, Terumo Cardiovascular Systems Corporation, Edwards Lifesciences Corporation, Medtronic plc, Cyberheart Incorporated, Thoratec Corporation, Cordis Corporation, Getinge Group, Atrion Corporation, Sorin S.p.A., Bioventrix Inc., Maquet GmbH & Co. KG, EndoPhotonix Inc., LivaNova PLC, CryoLife Inc., Artivion Inc.

North America was the largest region in the global cardiovascular surgery devices and equipment market in 2025. Western Europe was the second-largest region in the global cardiovascular surgery devices and equipment market. The regions covered in the cardiovascular surgery devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cardiovascular surgery devices and equipment market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.

Tariffs are impacting the cardiovascular surgery devices and equipment market by increasing costs of imported surgical instruments, ablation systems, heart-lung machines, electronic control units, and specialized disposables. Hospitals and surgical centers in North America and Europe are most affected due to reliance on imported high-end cardiac equipment, while Asia-Pacific experiences cost pressure on manufacturing and system integration. These tariffs are increasing procedural costs and delaying capital equipment upgrades. However, they are also encouraging regional manufacturing, localized sourcing of surgical components, and innovation in cost-optimized cardiovascular surgery solutions.

The cardiovascular surgery devices and equipment market research report is one of a series of new reports that provides cardiovascular surgery devices and equipment market statistics, including cardiovascular surgery devices and equipment industry global market size, regional shares, competitors with a cardiovascular surgery devices and equipment market share, detailed cardiovascular surgery devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the cardiovascular surgery devices and equipment industry. This cardiovascular surgery devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Cardiovascular surgery devices and equipment are crucial tools used in procedures focused on repairing structural defects in the cardiovascular system and addressing issues with valves and vessels.

The primary categories of cardiovascular surgery devices and equipment encompass beating heart surgery systems, cardiopulmonary bypass equipment, cardiac ablation devices, and perfusion disposables. Cardiopulmonary bypass equipment, particularly utilized in open-heart surgeries, is operated with precision. These tools find various applications in treating congenital heart defects, cardiac arrhythmia, coronary heart disease, congestive heart failure, among other medical needs. They are extensively employed in hospitals, diagnostic laboratories, research laboratories, as well as home and ambulatory care settings.

The cardiovascular surgery devices and equipment market consist of sales of perfusion disposables, beating heart surgery systems, cardiopulmonary bypass equipment, and cardiac ablation devices that are used for cardiovascular surgeries. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.